News Headlines Article

$259,000 Drug Hard To Swallow For Some Patients

A new drug discovered in San Diego is giving hope to some patients with cystic fibrosis. It’s giving others a severe case of sticker shock.

Approved by the FDA last month as the first drug to treat the most common genetic form of cystic fibrosis, Orkambi costs a quarter-million dollars per patient, per year. Some experts say our healthcare system can’t afford it. Meanwhile, many patients are hoping their insurance will cover the drug’s cost.